Shanghai Allist Pharmaceuticals Co Ltd Class A 688578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 64.30
- Day Range
- CNY 63.05–64.92
- 52-Week Range
- CNY 22.16–68.87
- Bid/Ask
- CNY 63.20 / CNY 63.21
- Market Cap
- CNY 28.44 Bil
- Volume/Avg
- 4.3 Mil / 5.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 32.11
- Price/Sales
- 11.55
- Dividend Yield (Trailing)
- 0.63%
- Dividend Yield (Forward)
- 0.63%
- Total Yield
- 0.63%
Company Profile
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,044
- Website
- http://www.allist.com.cn
Comparables
Valuation
|
Metric
|
688578
|
603896
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.11 | 20.65 | 14.95 |
Price/Book Value | 6.58 | 2.25 | 1.72 |
Price/Sales | 11.55 | 6.18 | 4.73 |
Price/Cash Flow | 27.06 | 17.28 | 13.74 |
Price/Earnings
688578
603896
301207
Financial Strength
|
Metric
|
688578
|
603896
|
301207
|
|---|---|---|---|
Quick Ratio | 7.91 | 3.29 | 3.16 |
Current Ratio | 8.35 | 3.64 | 3.65 |
Interest Coverage | 7,084.53 | 12.27 | 154.28 |
Quick Ratio
688578
603896
301207
Profitability
|
Metric
|
688578
|
603896
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 21.96% | 7.77% | 9.39% |
Return on Equity (Normalized) | 23.84% | 11.42% | 11.86% |
Return on Invested Capital (Normalized) | 22.94% | 7.56% | 11.24% |
Return on Assets
688578
603896
301207
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Ndhjxlxgml | Jqcrr | $626.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Ssjzcpkk | Jnlzf | $122.2 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vdwffym | Mzytxr | $115.2 Bil | |||
| Moderna Inc
MRNA
| Qbrymwjb | Pwygz | $52.8 Bil | |||
| argenx SE ADR
ARGX
| Njtgrfjz | Ylg | $22.6 Bil | |||
| BioNTech SE ADR
BNTX
| Wxmmcld | Bmfw | $21.3 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Zftdyjjp | Yhhywrm | $19.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Jjrjrgf | Ryxlssz | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Hmzqpnn | Dhfy | $13.2 Bil | |||
| Incyte Corp
INCY
| Glzpthscs | Gzbsbmk | $12.4 Bil |